A protocol for cell therapy infusion in neonates
Elizabeth K Baker, Euan M Wallace, Peter G Davis, Atul Malhotra, Susan E Jacobs, Stuart B Hooper, Rebecca Lim
Stem Cells Translational Medicine | WILEY | Published : 2021
Cell therapies for neonatal morbidities are progressing to early phase clinical trials. However, protocols for intravenous (IV) delivery of cell therapies to infants have not been evaluated. It has been assumed the cell dose prescribed is the dose delivered. Early in our clinical trial of human amnion epithelial cells (hAECs), we observed cells settling in the syringe and IV tubing used to deliver the suspension. The effect on dose delivery was unknown. We aimed to quantify this observation and determine an optimal protocol for IV delivery of hAECs to extremely preterm infants. A standard pediatric infusion protocol was modeled in the laboratory. A syringe pump delivered the hAEC suspension ..View full abstract
Awarded by NHMRC
This work was supported by NHMRC Program Grant #113902.